Posted by Michael Wonder on 26 Oct 2022
US FDA delays panel meet on Perrigo's OTC birth control pill
26 October 2022 - The US FDA has delayed a meeting of its advisory panel to discuss Perrigo's over the counter contraceptive, the drug maker said on Wednesday.
The meeting, scheduled for 18 November, was delayed to review additional information, and no new date has yet been set, in a setback for what was expected to be the first approved daily over the counter birth control pill in the US.
